WallStSmart
AUTL

Autolus Therapeutics Ltd

NASDAQ: AUTL · HEALTHCARE · BIOTECHNOLOGY

$1.60
-7.83% today

Updated 2026-06-05

Market cap
$465.75M
P/E ratio
P/S ratio
431.85x
EPS (TTM)
$-1.09
Dividend yield
52W range
$1 – $3
Volume
1.7M

Autolus Therapeutics Ltd (AUTL) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201520162017201820182019202020212022202320242025
Total assets$22.66M$34.18M$148.66M$217.66M$217.66M$303.53M$294.24M$405.56M$490.27M$375.38M$782.73M$589.07M
Cash & equivalents$10.18M$28.06M$137.07M$189.30M$189.30M$211.43M$154.09M$310.34M$382.44M$239.57M$227.38M$104.13M
Current assets$11.49M$30.93M$142.48M$199.14M$199.14M$249.26M$193.98M$346.95M$425.77M$275.30M$660.93M$435.92M
Total liabilities$1.95M$3.49M$6.06M$12.52M$12.52M$48.69M$84.20M$92.24M$191.60M$263.91M$355.40M$410.94M
Current liabilities$1.95M$2.73M$5.03M$12.52M$12.52M$24.98M$33.63M$28.55M$46.37M$44.74M$60.74M$73.44M
Long-term debt
Shareholder equity$20.71M$30.69M$142.60M$205.14M$205.14M$254.84M$210.03M$313.32M$298.67M$111.47M$427.32M$178.13M
Retained earnings$-9.33M$-28.18M$-47.90M$163.84M$163.84M$-237.15M$-379.24M$-521.34M$-670.18M$-878.56M$-1.10B$-1.39B
Accounts receivable$746869.00$2.18M$4.73M$6.81M$9.26M$30.52M$29.68M$68000.00$28.98M$1.05M$48.24M$75.26M
Inventory$2.21M$2.21M$7.81M$-29.68M$10.12M$14.16M$-23.50M$4.14M$33.21M
Goodwill

Frequently asked questions

What is Autolus Therapeutics Ltd's revenue?

Autolus Therapeutics Ltd's trailing twelve-month revenue is $1.08M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is AUTL?

In its most recent fiscal year, AUTL ran a gross margin of -27.83%, an operating margin of -372.45%, and a net margin of -381.40%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does AUTL generate?

AUTL produced $-302.66M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is AUTL's balance sheet healthy?

AUTL holds $104.13M in cash and equivalents against — in long-term debt, on $178.13M of shareholder equity. That debt is best read against the cash flow the business throws off each year.